臨床泌尿器科68巻4号

2014年04月発行

増刊号特集 前立腺癌の診療ナビゲーション―わかりやすく丁寧に！

Ⅷ　前立腺癌患者の症状の緩和

3．前立腺癌の再燃による排尿困難・血尿

著者： 佐藤文憲¹ 秦聡孝¹ 三股浩光¹

所属機関： ¹大分大学医学部腎泌尿器外科学講座

ページ範囲：P.293 - P.297

文献概要

055


Q　前立腺癌の再燃による排尿困難・血尿の対処法と注意点について教えてください。また，TURPの適応についても触れてください。


Point

●高度の血尿には30～40Gy程度の放射線療法が適している。

●下部尿路症状の原因として出口部閉塞のほかに排尿筋過活動の頻度が高い。

●TURPの切除は最小限とし，失禁のリスクから複数回手術は避ける。

参考文献

1）日本泌尿器科学会（編）：前立腺癌診療ガイドライン，2012年版．金原出版，東京，2012

2）中村敏之，加藤春雄，牧野武朗，他：前立腺癌による死亡前2年間に治療を必要とした症状の検討：泌尿器科紀要56：11-15，2010

3）Khafagy R, Shackley D, Samuel J, et al：Complications arising in the final year of life in men dying from advanced prostate cancer. J Palliat Med 10：705-711, 2007

4）Eastham JA, Kattan MW, Fearn P, et al；Transatlantic Prostate Group：Local progression among men with conservatively treated localized prostate cancer：results from the Transatlantic Prostate Group. Eur Urol 53：347-354, 2008

5）Krupski TL, Stukenborg GJ, Moon K, et al：The relationship of palliative transurethral resection of the prostate with disease progression in patients with prostate cancer. BJU Int 106：1477-1483, 2010

6）Nguyen DP, Giannarini G, Seiler R, et al：Local recurrence after retropubic radical prostatectomy for prostate cancer does not exclusively occur at the anastomotic site. BJU Int 112：E243-E249, 2013

7）Oefelein MG：Prognostic significance of obstructive uropathy in advanced prostate cancer. Urology 63：1117-1121, 2004

8）Hindson B, Turner S and Do V：Palliative radiation therapy for localized prostate symptoms in hormone refractory prostate cancer. Australas Radiol 51：584-588, 2007

9）Lankford SP, Pollack A and Zagars GK：Radiotherapy for regionally localized hormone refractory prostate cancer. Int J Radiat Oncol Biol Phys 33：907-912, 1995

10）Furuya Y, Akakura K, Akimoto S, et al：Radiotherapy for local progression in patients with hormone-refractory prostate cancer. Int J Urol 6：187-191, 1999

11）Gogna NK, Baxi S, Hickey B, et al：Split-course, high-dose palliative pelvic radiotherapy for locally progressive hormone-refractory prostate cancer. Int J Radiat Oncol Biol Phys 83：e205-e211, 2012

12）川上　理，河合恒雄，米瀬淳二，他：ホルモン抵抗性stage D2前立腺癌の局所再燃に対する対症的放射線療法．日泌尿会誌84：1681-1684，1993

13）Din OS, Thanvi N, Ferguson CJ, et al：Palliative prostate radiotherapy for symptomatic advanced prostate cancer. Radiother Oncol 93：192-196, 2009

14）No D, Osterberg EC, Otto B, et al：Evaluation of continence following 532nm laser prostatectomy for patients previously treated with radiation therapy or brachytherapy. Lasers Surg Med 45：358-361, 2013

15）Anast JW, Andriole GL and Grubb RL 2nd：Managing the local complications of locally advanced prostate cancer. Curr Urol Rep 8：211-216, 2007

16）Hanks GE, Leibel S and Kramer S：The dissemination of cancer by transurethral resection of locally advanced prostate cancer. J Urol 129：309-311, 1983

17）Moreno JG, O'Hara SM, Long JP, et al：Transrectal ultrasound-guided biopsy causes hematogenous dissemination of prostate cells as determined by RT-PCR. Urology 49：515-520, 1997

18）Marszalek M, Ponholzer A, Rauchenwald M, et al：Palliative transurethral resection of the prostate：functional outcome and impact on survival. BJU Int 99：56-59, 2007

19）Mazur AW and Thompson IM：Efficacy and morbidity of“channel”TURP. Urology 38：526-528, 1991

20）Sehgal A, Mandhani A, Gupta N, et al：Can the need for palliative transurethral prostatic resection in patients with advanced carcinoma of the prostate be predicted? J Endourol 19：546-549, 2005

21）Holzman M, Carlton CE Jr and Scardino PT：The frequency and morbidity of local tumor recurrence after definitive radiotherapy for stage C prostate cancer. J Urol 146：1578-1582, 1991

22）Mock S, Leapman M, Stock RG, et al：Risk of urinary incontinence following post-brachytherapy transurethral resection of the prostate and correlation with clinical and treatment parameters. J Urol 190：1805-1810, 2013

23）Kollmeier MA, Stock RG, Cesaretti J, et al：Urinary morbidity and incontinence following transurethral resection of the prostate after brachytherapy. J Urol 173：808-812, 2005

24）Mabjeesh NJ, Chen J, Stenger A, et al：Preimplant predictive factors of urinary retention after iodine 125 prostate brachytherapy. Urology 70：548-553, 2007

25）Patel H, Peddada AV, Zimmern PE, et al：Risk of incontinence with transurethral resection of the prostate after radiation therapy for prostate cancer. J Surg Oncol 64：127-129, 1997

26）Rom M, Waldert M, Schatzl G, et al：Bladder outlet obstruction（BOO）in men with castration-resistant prostate cancer. BJU Int 2013, Sep 5. doi：10.1111/bju.12438.［Epub ahead of print］

27）Gnanapragasam VJ and Leonard A：Does a pre-operative urodynamic diagnosis of bladder outflow obstruction improve outcomes from palliative transurethral prostatectomy? Urol Int 86：85-89, 2011